Clinical Trial Update: ZAP, US. Zomig for Appropriate for Primary Care [Phase 4]

View source ↗

Summary

Phase 4 update on Zomig (zolmitriptan) for migraine management in primary care, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zomig (Zolmitriptan)

Snippet

Sponsor: AstraZeneca | Conditions: Migraine | Phase 4 | Status: COMPLETED